Usana Health Sciences, Inc. (USNA) Tops Q4 EPS by 1c, Offers FY12 Guidance
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $14.96 +3.67%
Revenue Growth %: +5.0%
Financial Fact:
Other, net: -24K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +5.0%
Financial Fact:
Other, net: -24K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Usana Health Sciences, Inc. (NYSE: USNA) reported Q4 EPS of $0.87, $0.01 better than the analyst estimate of $0.86. Revenue for the quarter came in at $145.9 million versus the consensus estimate of $144.4 million.
Usana Health Sciences, Inc. sees FY2012 EPS of $3.35-$3.45, versus the consensus of $3.52. Usana Health Sciences, Inc. sees FY2012 revenue of $600-$615 million, versus the consensus of $603.4 million.
For earnings history and earnings-related data on Usana Health Sciences, Inc. (USNA) click here.
Usana Health Sciences, Inc. sees FY2012 EPS of $3.35-$3.45, versus the consensus of $3.52. Usana Health Sciences, Inc. sees FY2012 revenue of $600-$615 million, versus the consensus of $603.4 million.
For earnings history and earnings-related data on Usana Health Sciences, Inc. (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- RBC Capital Reiterates Outperform Rating on Aviva PLC (AV:LN) (AVVIY)
- ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
